CD163 and neoplasm: Subgroup A has a high expression of pro-tumor markers (CD163, PCOLCE2, IL-6) related to immune suppression and ECM remodeling while subgroup B has a low expression of pro-tumorigenic and immunosuppressive markers with an upregulation of genes linked to interferon signaling (Adhikary et al., 2017).